Home > Balance Sheet > CORONA REMEDIES

CORONA REMEDIES
Net Current Assets

    Back to Balance Sheet
CORONA REMEDIES is part of below Screeners ↓
Best Quarterly Growth Small Cap Stocks
COMMUNITY POLL
for CORONA REMEDIES
Please provide your vote to see the results

CORONA REMEDIES Last 5 Year Net Current Assets History

[Consolidated]

Mar2026Mar2025Mar2024Mar2023
Net Current Assets (Including Current Investments) ₹-13 Cr₹99 Cr₹66 Cr₹154 Cr

What is the latest Net Current Assets ratio of CORONA REMEDIES ?

The latest Net Current Assets ratio of CORONA REMEDIES is ₹-13 Cr based on Mar2026 Consolidated results.
Year Net Current Assets
Mar2026₹-13 Cr
Mar2025₹99 Cr
Mar2024₹66 Cr
Mar2023₹154 Cr

How is Net Current Assets of CORONA REMEDIES Trending?

Years Net Current Assets % Change
Mar2026 ₹-13 Cr
Negative
Mar2025 ₹99 Cr
51.06
Mar2024 ₹66 Cr
-57.35
Mar2023 ₹154 Cr -

Compare Net Current Assets of peers of CORONA REMEDIES

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
CORONA REMEDIES ₹12,945.9 Cr -4.5% 0.4% NA Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹444,717.0 Cr -0.8% -2.5% 11.9% Stock Analytics
DIVIS LABORATORIES ₹255,115.0 Cr 1.9% 6.6% 55.1% Stock Analytics
TORRENT PHARMACEUTICALS ₹189,613.0 Cr 0.3% 2% 35.9% Stock Analytics
CIPLA ₹112,876.0 Cr 0.9% -0.8% -10.9% Stock Analytics
DR REDDYS LABORATORIES ₹100,395.0 Cr 0.1% 1.4% -9.3% Stock Analytics


CORONA REMEDIES Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
CORONA REMEDIES

-4.5%

0.4%

NA
SENSEX

-0.5%

-4.8%

-11%


You may also like the below Video Courses